000590 启迪药业
已收盘 03-29 15:00:00
资讯
新帖
简况
启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%
智通财经网 · 03-27 19:49
启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%
启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对
市场资讯 · 01-15
启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对
启迪药业(000590.SZ)拟对启迪化工(医药)科技园项目追加投资5326.75万元
智通财经网 · 01-11
启迪药业(000590.SZ)拟对启迪化工(医药)科技园项目追加投资5326.75万元
启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品
智通财经网 · 01-11
启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品
启迪药业10.0%涨停,总市值24.5亿元
金融界网站 · 01-05
启迪药业10.0%涨停,总市值24.5亿元
加载更多
公司概况
公司名称:
启迪药业集团股份公司
所属行业:
医药制造业
上市日期:
1996-01-19
主营业务:
启迪药业集团股份公司主营业务是研究、开发中国中药传统秘方、验方和西药制剂。公司始终致力于医药大健康领域的拓展深耕,产品涵盖中药、化药、保健食品三大板块,主要产品包括中成药、西药制剂以及药食同源保健食品。作为传统中、西药生产与销售的企业,品牌与品种优势突出,是湖南省主要的医药企业之一。公司具有现代化的生产设备,产品“古汉养生精”因其独特配方,曾被评为国家秘密技术项目品种和国家中药保护品种,产品质量被市场及客户高度认可,树立了较好的市场口碑。
发行价格:
6.00
{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"启迪药业","latestPrice":7.46,"timestamp":1711695819000,"preClose":7.43,"halted":0,"volume":7051200,"delay":0,"floatShares":239000000,"shares":239000000,"eps":0.1351,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"03-29 15:00:00","open":7.44,"high":7.5,"low":7.25,"amount":52162700,"amplitude":0.0336,"askPrice":7.47,"askSize":451,"bidPrice":7.46,"bidSize":456,"shortable":0,"etf":0,"ttmEps":0.1351,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1711935000000},"adr":0,"adjPreClose":7.43,"symbolType":"stock","openAndCloseTimeList":[[1711675800000,1711683000000],[1711688400000,1711695600000]],"highLimit":8.17,"lowLimit":6.69,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"pbRate":2.46,"roa":"--","roe":"3.55%","epsLYR":0.1054,"committee":0.357159,"marketValue":1786000000,"floatMarketCap":1786000000,"peRate":55.218354,"changeRate":0.004,"turnoverRate":0.0295,"status":0},"requestUrl":"/m/hq/s/000590","defaultTab":"news","newsList":[{"id":"2422998556","title":"启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422998556","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422998556?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:49","pubTimestamp":1711540140,"startTime":"0","endTime":"0","summary":"启迪药业发布2023年年度报告,该公司营业收入为4.05亿元,同比增长15.44%。归属于上市公司股东的净利润为2524.68万元,同比增长39.41%。归属于上市公司股东的扣除非经常性损益的净亏损为465.05万元。基本每股收益为0.1054元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2403808390","title":"启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对","url":"https://stock-news.laohu8.com/highlight/detail?id=2403808390","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2403808390?lang=zh_cn&edition=full","pubTime":"2024-01-15 07:47","pubTimestamp":1705276020,"startTime":"0","endTime":"0","summary":" 手头并不宽裕的情况下,启迪药业依然坚持高溢价收购。 1月12日,启迪药业公告显示,公司拟以现金人民币1.41亿元的对价,收购名实药业55%股权。其中,倪小桥还是副董事长、党委书记,为公司“二把手”。 倪小桥、唐婷认为,名实药业缺主打产品,未来市场核心竞争力弱。 当前,启迪药业业绩并不理想,公司2023年前三季度净利润仅643.01万元,同比下滑59.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402244894","title":"启迪药业(000590.SZ)拟对启迪化工(医药)科技园项目追加投资5326.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402244894","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2402244894?lang=zh_cn&edition=full","pubTime":"2024-01-11 21:00","pubTimestamp":1704978000,"startTime":"0","endTime":"0","summary":"启迪药业发布公告,2019年10月28日,公司第八届董事会临时会议审议通过了《关于全资子公司拟对外投资建设古汉医药科技园项目并签订项目框架协议的议案》,决定以自有资金及自筹资金投资9956.59万元建设古汉医药科技园项目,计划建设制剂车间、仓库、辅助设施用房、办公科研楼、污水处理设施等工程。因此,为保障项目建设顺利推进,拟在项目原总投资计划金额9956.59万元的基础上,按照设计概算金额增加投资5326.75万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inacemiy2185145.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inacemiy2185145.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402242256","title":"启迪药业(000590.SZ)拟收购名实药业55%股权 延伸产品线至大健康保健食品及功能性食品","url":"https://stock-news.laohu8.com/highlight/detail?id=2402242256","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2402242256?lang=zh_cn&edition=full","pubTime":"2024-01-11 20:54","pubTimestamp":1704977640,"startTime":"0","endTime":"0","summary":"公司拟以现金人民币1.41亿元的对价收购转让方持有的名实药业55%股权。名实药业二级子公司华凯保健品持有2个国产保健食品批件,名实药业关联企业健恒生物持有2个保健食品批件。公司表示,本次公司受让名实药业55%股权后,通过本次收购上市公司将产品线延伸至大健康保健食品及功能性食品,有利于化解上市公司产品单一的经营风险,丰富上市公司产品线,实现双方销售渠道的互补,增厚上市公司经营护城河。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-01-11/doc-inacemiv2571142.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401081473","title":"启迪药业10.0%涨停,总市值24.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401081473","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2401081473?lang=zh_cn&edition=full","pubTime":"2024-01-05 11:10","pubTimestamp":1704424200,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界1月5日,启迪药业盘中10.0%涨停,截至11:08,报10.23元/股,成交3676.01万元,换手率1.59%,总市值24.5亿元。截至9月30日,启迪药业股东户数2.12万,人均流通股1.13万股。2023年1月-9月,启迪药业实现营业收入2.75亿元,同比增长16.10%;归属净利润643.01万元,同比减少59.04%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-01-05/doc-inaamvhk9520687.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-01-05/doc-inaamvhk9520687.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","stockEarnings":[{"period":"1week","weight":-0.0275},{"period":"1month","weight":0.0435},{"period":"3month","weight":-0.1708},{"period":"6month","weight":-0.1595},{"period":"1year","weight":-0.1489},{"period":"ytd","weight":-0.1708}],"companyName":"启迪药业集团股份公司","boardCode":"AI0027","perCapita":"11181股","boardName":"医药制造业","registeredCapital":"23947万元","compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.0016},{"period":"3month","weight":0.012},{"period":"6month","weight":-0.0321},{"period":"1year","weight":-0.0708},{"period":"ytd","weight":0.012}],"survey":" 启迪药业集团股份公司主营业务是研究、开发中国中药传统秘方、验方和西药制剂。公司始终致力于医药大健康领域的拓展深耕,产品涵盖中药、化药、保健食品三大板块,主要产品包括中成药、西药制剂以及药食同源保健食品。作为传统中、西药生产与销售的企业,品牌与品种优势突出,是湖南省主要的医药企业之一。公司具有现代化的生产设备,产品“古汉养生精”因其独特配方,曾被评为国家秘密技术项目品种和国家中药保护品种,产品质量被市场及客户高度认可,树立了较好的市场口碑。","serverTime":1711720347562,"listedPrice":6,"stockholders":"21408人(较上一季度增加13.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"启迪药业,000590,启迪药业股票,启迪药业股票老虎,启迪药业股票老虎国际,启迪药业行情,启迪药业股票行情,启迪药业股价,启迪药业股市,启迪药业股票价格,启迪药业股票交易,启迪药业股票购买,启迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}